Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
The side effects most frequently reported in the clinical literature and in real-world use are typically mild and dose-related: Injection site reaction: Brief redness, mild soreness, or small bruising at the injection site
Cosmetic Peptide Comparison: BPC-157 vs TB-500, IGF-1 vs IGF-1 LR3, Semax vs Selank, GHRP-2 vs Ipamorelin Cosmetic Peptide Comparison: BPC-157 vs TB-500, IGF-1 vs IGF-1 LR3, Semax vs Selank, and GHRP-2 vs Ipamorelin At a glance BPC-157 half-life / approximately 4 hours (subcutaneous or intramuscular) TB-500 half-life / longer systemic distribution, dosed 2-4 mg twice weekly IGF-1 LR3 active window / up to 20 hours vs ~20 minutes for native IGF-1 Semax mechanism / upregulates BDNF and dopamine receptor sensitivity Selank mechanism / enhances GABA-A tone and reduces IL-6 by ~30% in animal models GHRP-2 GH pulse / strong but co-elevates cortisol and prolactin Ipamorelin GH pulse / selective
Prescription recommended but not always required
Therapeutic efficacy of platelet-derived products on testicular T/D injury Testicular ischemia/reperfusion (I/R) injury, commonly resulting from torsion and subsequent detorsion, represents a critical cause of male infertility
Both peptides serve distinct purposes in hormone therapy, yet they share a common goal of improving metabolic health and overall well-being
And at the maximum studied dose of 12 mg, average weight loss hit 24.2% at 48 weeks
